Serum C reactive protein predicts humoral response after BNT162b2 booster administration.

Salvagno, Gian Luca; Henry, Brandon M; Pighi, Laura; De Nitto, Simone; Lippi, Giuseppe

Salvagno, Gian Luca; Henry, Brandon M; Pighi, Laura; De Nitto, Simone; Lippi, Giuseppe.

Salvagno GL; Section of Clinical Biochemistry, University of Verona, Verona, Italy; Service of Laboratory Medicine, Pederzoli Hospital, Peschiera del Garda, Italy.
Henry BM; Clinical Laboratory, Division of Nephrology and Hypertension, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
Pighi L; Section of Clinical Biochemistry, University of Verona, Verona, Italy; Service of Laboratory Medicine, Pederzoli Hospital, Peschiera del Garda, Italy.
De Nitto S; Section of Clinical Biochemistry, University of Verona, Verona, Italy; Service of Laboratory Medicine, Pederzoli Hospital, Peschiera del Garda, Italy.
Lippi G; Section of Clinical Biochemistry, University of Verona, Verona, Italy. Electronic address: giuseppe.lippi@univr.it.

J Infect ; 85(1): e24-e25, 2022 07.

Article in English | MEDLINE | ID: covidwho-1778313

Subject(s)

BNT162 Vaccine; C-Reactive Protein; Antibodies, Viral; Humans; Immunity, Humoral; Immunization, Secondary; Vaccination

Keywords

Antibodies; C reactive protein; COVID-19; SARS-CoV-2; Vaccination

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: C-Reactive Protein / BNT162 Vaccine Type of study: Prognostic study Topics: Vaccines Limits: Humans Language: English Journal: J Infect Year: 2022 Document Type: Article Affiliation country: J.jinf.2022.04.015

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google